Safety and effectiveness of direct oral anticoagulants in patients with nephrotic syndrome: a report of 21 cases
Abstract Background Nephrotic syndrome (NS) is associated with increased risk of thromboembolic events (TE) adding to the morbidity and mortality. International guidelines recommend prophylactic anticoagulation in patients with NS and high risk of TE, but no studies have identified the optimal type...
Main Authors: | Sarah Kelddal, Anne-Mette Hvas, Erik Lerkevang Grove, Henrik Birn |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12882-022-02929-x |
Similar Items
-
Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome
by: Tess Van Meerhaeghe, et al.
Published: (2022-10-01) -
Congenital Nephrotic Syndrome: Case Report and Review of Literature
by: Murat Konak, et al.
Published: (2012-04-01) -
Hypovolemic Shock Complicating Nephrotic Syndrome in a Child
by: Lydia Kosnadi, et al.
Published: (2019-07-01) -
Urokinase prophylactic anticoagulation in children with nephrotic syndrome: a multicenter retrospective cohort study
by: Zhen Wang, et al.
Published: (2024-02-01) -
Congenital nephrotic syndrome
by: Claudia Fanni, et al.
Published: (2014-10-01)